The following table presents the OPTAVIA segment's revenue, significant segment expenses, and segment net income for the three months ended June 30, 2025 and 2024, respectively:


	June 30, 2025		June 30, 2024
Revenue	$	105,555	$	168,558
Less:
Cost of sales	28,911		45,120
Selling, marketing, and after sales support	50,485		80,413
Distribution	5,305		18,549
Technology	10,566		13,371
Administrative and corporate support functions	8,685		16,527
Equity compensation	2,669		2,454
Other loss (income) (1)	(3,941)		2,774
Provision (benefit) for income taxes	395		(2,496)
Segment net income (loss)	$	2,480	$	(8,154)

Reconciliation of profit or loss
Adjustments and reconciling items	—		—

Consolidated net income (loss)	$	2,480	$	(8,154)

(1) Other loss (income) included within Segment net income (loss) includes interest income, interest expense, and realized and unrealized gains and losses on LifeMD common stock.

The following table presents the OPTAVIA segment's revenue, significant segment expenses, and segment net income for the six months ended June 30, 2025 and 2024, respectively:


	June 30, 2025		June 30, 2024
Revenue	$	221,283	$	343,297
Less:
Cost of sales	60,395		92,567
Selling, marketing, and after sales support	110,340		167,693
Distribution	9,831		26,058
Technology	21,608		26,170
Administrative and corporate support functions	16,667		26,121
Equity compensation	4,771		4,624
Other income (1)	(5,730)		(872)
Provision for income taxes	1,693		773
Segment net income	$	1,708	$	163

Reconciliation of profit or loss
Adjustments and reconciling items	—		—

Consolidated net income	$	1,708	$	163

(1) Other income included within Segment net income includes interest income, interest expense, and realized and unrealized gains and losses on LifeMD common stock.